US pharma major Eli Lilly, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive top-line ...

The New Drug Application (NDA) for the combination of Elunate (fruquintinib) and TYVYT (sintilimab injection) has been ...

Genesis Molecular AI and Incyte announced a new kind of deal, with Incyte’s proprietary experimental data powering ...

Privately-held UK based AMR Bio has announced its launch as a clinical phase biotechnology company focused on one of the most ...

American States are rolling out complex drug price-setting efforts - but there is no evidence yet that patients are or will ...

Scenic Biotech has progressed enormously since it was founded in 2017 as a spin-out from the Netherlands Cancer Institute and ...

A clinical-stage Israeli biotech advancing steroid-free therapies for ocular diseases, with a lead program in Phase III ...

Italian rare disease specialist Chiesi has secured approval from the UK Medicines and Healthcare products Regulatory Agency ...

Schizophrenia is a persistent and disabling mental illness that can impact all aspects of an individual’s life, including ...

California-based obesity-focused clinical-stage pharma Aardvark Therapeutics saw its shares tumble nearly 26% to $4.99, after it announced that the US Food and Drug Administration (FDA) has placed a ...

US biotech Regenxbio announced top-line and interim functional data from the pivotal Phase III portion of the Phase I/II/III ...

Bristol Myers Squibb’s Eliquis (apixaban) is on course for one of the largest single-asset revenue collapses in ...